The must-attend event in the fight against childhood cancer
On Saturday, February 7, 2026, the FAST Symposium will take place at Maison Châteauform’ Metropolitan, located at 13ter boulevard Berthier in Paris’ 17th arrondissement. From 10 a.m. to 4 p.m., this 13th edition will mark a particularly symbolic milestone: 15 years of commitment by Imagine for Margo in the fight against pediatric cancers.
Fifteen years dedicated to research and families
Since its creation, Imagine for Margo has funded 92 French and European research projects for a total of €28 million. These fifteen years of action have supported major scientific advances while also providing support to patients and families facing the challenges of pediatric cancer.
Despite significant progress in the care of children and adolescents with cancer, the needs remain considerable. Pediatric cancer research requires continued support to foster therapeutic innovation and meet the expectations of families.
FAST Symposium 2026 program
Morning session: State of pediatric cancer research
The morning will focus on reviewing research progress and analyzing current needs in the fight against childhood cancers. Three renowned researchers will present their work in key priority areas:
- Pediatric brain tumors
- Childhood myeloid leukemias
- Reducing the side effects of cancer treatments
A roundtable discussion on clinical research will follow these scientific presentations. Although progress has been made in recent years, access to innovative therapies for children with cancer remains insufficient. Discussions will focus on the need to strengthen clinical research centers, accelerate pediatric clinical trials, and improve clinical research funding.
Afternoon session: Patient support and therapeutic innovation
The afternoon will begin with a roundtable dedicated to the needs of patients and families. A pediatric cancer diagnosis has a lasting impact on the lives of the affected child, their parents, and their siblings. This session will explore the psychological and social impact of the disease and discuss practical ways to improve family support across France.
The day will conclude with a discussion on the role of biotech and medtech companies in driving innovation against pediatric cancers. Several success stories will be presented, illustrating how these companies contribute to the development of new treatments. Speakers will also identify key levers to strengthen their impact on pediatric cancer research.
FAST: A unique symposium in France
The FAST Symposium stands out as a unique event in the French pediatric oncology landscape. It brings together researchers, clinicians, industry leaders, regulators, and families in one place, creating a rare and valuable space for dialogue.
This exceptional gathering allows every stakeholder involved in care and research to directly engage with families affected by pediatric cancer, pharmaceutical professionals, innovative startups, and regulatory authorities. This diversity of participants is the strength of the event and helps foster new ideas, meaningful collaborations, and strategic directions for future actions.
Why attend FAST Symposium 2026?
Whether you are a researcher, physician, healthcare professional, biotech representative, parent of a child with cancer, or simply committed to the fight against pediatric cancers, FAST Symposium 2026 is a unique opportunity to:
- Discover the latest advances in pediatric cancer research
- Understand the current challenges in pediatric clinical research
- Connect with leading experts in pediatric oncology
- Contribute to improving support for families
- Identify promising therapeutic innovations
- Build synergies between all stakeholders involved
Practical information
- Date: Saturday, February 7, 2026
- Time: 10 a.m. – 4 p.m.
- Location: Maison Châteauform’ Metropolitan
13ter boulevard Berthier, 75017 Paris - Registration: Free but mandatory
For this 13th edition, FAST will more than ever be a space for discussion and collaboration, helping to shape tomorrow’s solutions to defeat pediatric cancers.